Group One Trading’s Genetic Technologies Ltd. GENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,242
Closed -$21.8K 8922
2021
Q4
$21K Sell
2,242
-10,240
-82% -$131K ﹤0.01% 6964
2021
Q3
$193K Sell
12,482
-3,420
-22% -$58.7K ﹤0.01% 5216
2021
Q2
$338K Buy
15,902
+6,135
+63% +$124K ﹤0.01% 4659
2021
Q1
$204K Buy
9,767
+5,853
+150% +$134K ﹤0.01% 5011
2020
Q4
$70K Buy
3,914
+1,074
+38% +$17.7K ﹤0.01% 4802
2020
Q3
$49K Buy
+2,840
New +$52.9K ﹤0.01% 4664
2014
Q3
Sell
-10
Closed -$1K 5535
2014
Q2
$1K Sell
10
-5
-33% -$598 ﹤0.01% 5076
2014
Q1
$2K Buy
15
+11
+275% +$1.76K ﹤0.01% 5007
2013
Q4
$1K Buy
+4
New +$744 ﹤0.01% 5141
2013
Q3
Sell
-27
Closed -$6.43K 5671
2013
Q2
$6K Buy
+27
New +$7K ﹤0.01% 4639

Other funds holding GENE

Group One Trading's GENE Position: Q1 2022 in Review

Group One Trading sold out of Genetic Technologies Ltd. (GENE) in Q1 2022, closing a stake of 2,242 shares — an estimated $21.8K sold.

Group One Trading first reported a position in GENE in Q2 2013 and held it in 10 quarters. The position peaked at $338K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q1 2022.

  • Group One Trading reported no remaining Genetic Technologies Ltd. position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 2,242 Genetic Technologies Ltd. shares in Q1 2022, an estimated $21.8K.
  • Group One Trading first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Genetic Technologies Ltd. position peaked at $338K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.